微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 62.15% | -8.11% | -2.43% | 48/140 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 63.7% | -9.55% | -0.89% | 48/140 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 64.27% | -9.19% | -1.58% | 45/140 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 65.3% | -7.66% | -3.46% | 37/140 | 52.43% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 67.64% | -0.82% | -3.95% | 29/140 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 70.43% | 2.1% | -0.49% | 26/140 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 70.78% | 2.76% | 0.08% | 25/140 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 70.72% | 3.95% | 3.69% | 25/140 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 68.2% | -1.72% | -1.13% | 36/140 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 68.98% | 0.61% | 0.15% | 30/140 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 68.88% | 2% | 1.25% | 31/140 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 68.03% | -2.67% | -1.97% | 34/140 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 69.39% | 2% | 1.21% | 29/140 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 68.56% | -1.58% | -1.9% | 32/140 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 69.89% | -7.28% | 0.33% | 28/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2021-12-31 | 69.67% | 5.42% | 5.42% | 36/140 | 57.98% | 三友医疗 | 90.29% | 行业排名> |
| 2020-12-31 | 66.08% | -11.76% | -12.33% | 54/140 | 60.12% | 三友医疗 | 90.73% | 行业排名> |
| 2017-06-30 | 75.38% | 2% | 0.65% | 12/140 | 54.85% | 三友医疗 | 90.5% | 行业排名> |
| 2016-12-31 | 74.89% | 2% | 2% | 20/140 | 57.35% | 三友医疗 | 90.29% | 行业排名> |